Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liver Spare the Nephron (STN) Study
NCT00118742Phase 4Completed
- Sponsor
- Roche
- Start
- Aug 2005
- Primary completion
- Jul 2008
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 4, randomised, open-label trial in Liver transplant rejection comparing CellCept + CNI with CellCept + Sirolimus (2 arms). Primary endpoint: Glomerular Filtration Rate at 12 months. Started Aug 2005; status: completed.
02
Drugs
mycophenolate mofetilsirolimus
03
Conditions
Liver transplant rejection
Beyond the preview
Go deeper on NCT00118742.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00118742.